Alexion recalls some Soliris batches

Share this article:

Pricey rare disease drug Soliris is being recalled. Manufacturer Alexion noted in an 8K that it was recalling less than 1% of its stock after tests showed visible particles in the medication. The company says replacing the drugs will cost between $10 million and $25 million, and that the recall affected only products in the US.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.